Fortis Healthcare’s JivanaAI Wins Catalyst Innovation Grant at Doctors AI Global Summit 2025
Rahul Bhargava, Director and Head of Hematology, Hematoncology and Stem Cell Transplant at Fortis Health Care, posted on LinkedIn:
”JivanaAI team from Fortis Healthcare Gurugram (FMRI), we won the catalyst innovation grant at the most prestigious healthtech conference: Doctors AI Global Summit. Happening this weekend at Bengaluru, Radisson Blu Atria.
5 posters, 1 oral presentation, and a stall to showcase our innovations because of our landmark “ThalSaarthi”, which got us the prize.
A team led by and driven by young professionals with unlimited energy and enthusiasm can drive the nation towards the summit of excellence. Congratulations to the JivanaAI team led by Swarsat K. Nath, powered by Yashpal Singh Rawat, Dr Ritu Mittal Garg, and Fortis Healthcare, DBT/WT India Alliance, AI Investor, Health Parliament, Shrinidhi Nathany, Aastha Gupta, Ajey Maharaj, Amit Pal Singh Raina
Congrats to the entire team.”
Stay updated with Hemostasis Today.
-
Aug 24, 2026, 18:13Chokri Ben Lamine: Ruxolitinib – Comprehensive Clinical Reference
-
Aug 24, 2026, 18:10Yazan Abou-Ismail: ClotCast Episode 8 – What Are Platelets?
-
Aug 24, 2026, 17:11Kristin Neves: Which Hematologic Parameters Guide Your PV Treatment Decisions?
-
Aug 24, 2026, 17:00Should Hormone Therapy Automatically Stop After a Thrombosis? – Thrombosis Canada
-
Aug 24, 2026, 16:52Davide Capodanno: 10 Trials to Watch at the ESC Hot Lines
-
Aug 24, 2026, 16:48Mohd Ashhad: The Science Behind a Safe Transfusion
-
Aug 24, 2026, 16:38PCSK9i Is a Powerful Lipid-Lowering Strategy – But Is It Also Anti-Inflammatory?- JACC Journals
-
Aug 24, 2026, 16:36Alejandro González Veliz։ Does ACC/AHA Lesion Complexity Still Matter?
-
Aug 24, 2026, 16:21Kamlesh Darji: Paraneoplastic Syndromes – Tumor with or without Mediator